ABL Bio Stock

ABL Bio Liabilities 2024

ABL Bio Liabilities

86.07 B KRW

Ticker

298380.KQ

ISIN

KR7298380007

In 2024, ABL Bio's total liabilities amounted to 86.07 B KRW, a -25.59% difference from the 115.67 B KRW total liabilities in the previous year.

ABL Bio Aktienanalyse

What does ABL Bio do?

ABL Bio ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing ABL Bio's Liabilities

ABL Bio's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating ABL Bio's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing ABL Bio's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

ABL Bio's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in ABL Bio’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about ABL Bio stock

What is the level of liabilities of ABL Bio this year?

ABL Bio has a debt balance of 86.07 B KRW this year.

What were the liabilities of ABL Bio compared to the previous year?

The liabilities of ABL Bio have increased by -25.59% dropped compared to the previous year.

What are the consequences of high debt for investors of ABL Bio?

High liabilities can pose a risk for investors of ABL Bio, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in ABL Bio?

Low liabilities mean that ABL Bio has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of ABL Bio affect the company?

An increase in liabilities of ABL Bio can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of ABL Bio affect the company?

A decrease in the liabilities of ABL Bio can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of ABL Bio?

Some factors that can influence the liabilities of ABL Bio include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of ABL Bio so important for investors?

The liabilities of ABL Bio are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can ABL Bio take to modify the liabilities?

To change its liabilities, ABL Bio can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does ABL Bio pay?

Over the past 12 months, ABL Bio paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, ABL Bio is expected to pay a dividend of 0 KRW.

What is the dividend yield of ABL Bio?

The current dividend yield of ABL Bio is .

When does ABL Bio pay dividends?

ABL Bio pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of ABL Bio?

ABL Bio paid dividends every year for the past 0 years.

What is the dividend of ABL Bio?

For the upcoming 12 months, dividends amounting to 0 KRW are expected. This corresponds to a dividend yield of 0 %.

In which sector is ABL Bio located?

ABL Bio is assigned to the 'Health' sector.

Wann musste ich die Aktien von ABL Bio kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of ABL Bio from 9/9/2024 amounting to 0 KRW, you needed to have the stock in your portfolio before the ex-date on 9/9/2024.

When did ABL Bio pay the last dividend?

The last dividend was paid out on 9/9/2024.

What was the dividend of ABL Bio in the year 2023?

In the year 2023, ABL Bio distributed 0 KRW as dividends.

In which currency does ABL Bio pay out the dividend?

The dividends of ABL Bio are distributed in KRW.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von ABL Bio

Our stock analysis for ABL Bio Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of ABL Bio Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.